• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Obstetrics

Spontaneous early term delivery associated with subsequent preterm birth

bys25qthea
November 2, 2013
in Obstetrics
Reading Time: 3 mins read
Antepartum and intrapartum events both linked to neonatal HIE
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD 

1. Spontaneous delivery in early term (37-39 weeks) may be associated with subsequent spontaneous preterm labor. 

2. Labor induction of term pregnancies is associated with decreased risk of subsequent spontaneous preterm birth (sPTB). 

Evidence Rating Level: 2 (Good)            

Study Rundown: This study showed that women who went into spontaneous labor in early term (37-39 weeks estimated gestational age) were more likely to experience subsequent spontaneous preterm labor. Results also found that induction of term pregnancies was associated with decreased odds of subsequent sPTB. The present work is the first study to evaluate the association between spontaneous vs. induced labor in term and early term pregnancies with sPTB in subsequent pregnancies.

Limitations of the study include retrospective design and a control group matched only for date and time of delivery. Future studies might include a prospective cohort study and evaluation of trends between groups better matched for other factors that may influence risk of sPTB.

RELATED REPORTS

Probiotic supplementation is associated with reduced risk of death and necrotizing enterocolitis among preterm infants

Preterm infants have increased risk of psychological and physical health comorbidities at adulthood

Click to read the study in AJOG

Relevant Reading: Prediction and prevention of recurrent spontaneous preterm birth

Study Author, Dr. Lisa Levine, MD, MSCE, talks to 2 Minute Medicine: University of Pennsylvania, Department of Obstetrics & Gynecology, Division of Maternal & Fetal Medicine

“Our study results are in keeping with the emerging evidence that deliveries in the early term period have outcomes different than deliveries after 39 weeks. The findings from our study give credence to the concept that not all ‘term’ deliveries have the same outcomes, nor do they have the same implications for future pregnancies.”

In-Depth [retrospective cohort study]: This study used medical records of women undergoing induced labor (n=622) and spontaneous labor (n=265) who delivered a second baby at the same hospital to examine whether labor induction (defined as employment of cervical foley, artificial rupture of membranes, prostaglandin and/or pitocin) increases likelihood of sPTB. Outcomes evaluated at the second delivery were spontaneous labor and delivery or premature rupture of membranes at <37 weeks gestation, mode of delivery, and sPTB at <34 weeks and <24 weeks.

Women who required labor induction for delivery at the index pregnancy were less likely to experience sPTB (OR 0.55, CI 0.31-0.97). In women who experienced spontaneous onset of labor, those who spontaneously delivered early term (37-39wga) pregnancies were more likely to experience subsequent sPTB (OR 3.0, CI 1.44-6.16, p=0.003), while those who delivered spontaneously after 38.9wga were no less likely (p=0.8).

By Denise Pong, MPH and Leah Hawkins, MD, MPH

More from this author: Donor oocyte IVF making strides, Shortage of evidence assessing teratogenic drugs, HPV infection associated with preeclampsia, Conservative treatment of recurrent ovarian tumors may preserve fertility, Recommendations for intrapartum management of TOLAC

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: pretermpreterm births
Previous Post

High cumulative-dose isotretinoin treatment decreases risk of acne relapse

Next Post

Two-pronged atorvastatin administration for prophylaxis of acute GVHD

RelatedReports

A young boy stands with a stylized representation of the gastrointestinal tract and immunoglobulin shields, surrounded by images of pathogens and IV equipment.
Emergency

Probiotic supplementation is associated with reduced risk of death and necrotizing enterocolitis among preterm infants

October 2, 2026
Large proportion of late preterm infants and older admitted to the NICU
Chronic Disease

Preterm infants have increased risk of psychological and physical health comorbidities at adulthood

July 31, 2025
#VisualAbstract: Mydriatic Microdrops are Non-inferior for Retinopathy of Prematurity Screening Compared to Standard Drops
StudyGraphics

#VisualAbstract: Mydriatic Microdrops are Non-inferior for Retinopathy of Prematurity Screening Compared to Standard Drops

January 20, 2025
Prenatal Systemic Glucocorticoid Exposure and an Increased Risk of Future Mental Disorders
StudyGraphics

Prenatal Systemic Glucocorticoid Exposure and an Increased Risk of Future Mental Disorders

January 16, 2025
Next Post
Two-pronged atorvastatin administration for prophylaxis of acute GVHD

Two-pronged atorvastatin administration for prophylaxis of acute GVHD

Patient transfers to trauma centers often unnecessary

2 Minute Medicine Rewind October 28 - November 3, 2013

Undervaccination becoming more common, associated with increased patient admission rates

Shared decision-making associated with increased parental resistance to vaccinations

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tarlatamab plus durvalumab improved survival versus durvalumab alone in extensive-stage small cell lung cancer, Amgen reports in interim phase 3 results
  • Sacituzumab tirumotecan improved overall survival versus platinum chemotherapy in company-reported final phase 3 results
  • Camupepimut did not improve disease-free survival versus observation in pancreatic cancer in the randomized phase 2 AMPLIFY-7P trial
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.